Evidence map›Paper›PMID 41811946›Full record

ArticleScience advances2026

miR-203 facilitates timely cell fate transitions via epigenetic modulation during early embryogenesis.

José González-Martínez, Agustín Sánchez-Belmonte, Estefanía Ayala, Beatriz Escobar, Jesús Gómez, Alejandro García-Díaz, Enrique Nogueira, Jaime Muñoz, Anna Melati, Andreas Brandauer and 5 more

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Exit from totipotency in mammals: an epigenetic perspective.Frontiers in cell and developmental biology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

José González-MartínezCell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.ORCID 0000-0002-3850-6803
Agustín Sánchez-BelmonteCell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.ORCID 0000-0001-6936-1873
Estefanía AyalaCell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.ORCID 0009-0002-9279-9421
Beatriz EscobarMouse Genome Editing Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.ORCID 0000-0002-2246-352X
Jesús GómezConfocal Microscopy Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.ORCID 0000-0002-8567-8907
Alejandro García-DíazCell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.ORCID 0009-0003-6818-1450
Enrique NogueiraCell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.ORCID 0000-0002-8317-6866
Jaime MuñozMouse Genome Editing Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.ORCID 0009-0001-5709-5050
Anna MelatiCell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.ORCID 0000-0002-2394-734X
Andreas BrandauerCell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.ORCID 0009-0004-4712-9271
Daniel Giménez-LlorenteConfocal Microscopy Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.ORCID 0000-0003-2284-9761
Isabel PesetConfocal Microscopy Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Ana LosadaChromosome Dynamics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.ORCID 0000-0001-5251-3383
Sagrario OrtegaMouse Genome Editing Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.ORCID 0000-0002-1865-7102
Marcos MalumbresCell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.ORCID 0000-0002-0829-6315

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Commonly expressed at developmental transitions, microRNAs operate as fine-tuners of gene expression to facilitate cell fate acquisition and lineage segregation. Nevertheless, how they might regulate the earliest developmental transitions in early mammalian embryogenesis remains obscure. Here, in a strictly in vivo approach based on genetically engineered mouse models and single-cell RNA sequencing, we identify microRNA-203 (miR-203) as a critical regulator of timely progression in preimplantation mouse embryos. Genetically engineered mouse models including a generated embryonic reporter (early embryo reporter) transgenic mouse carrying murine endogenous retrovirus-L (MERVL)-Tomato and SRY-box 2 (Sox2)-green fluorescent protein transgenes show that loss of miR-203 slows down early preimplantation development leading to the accumulation of embryos with high expression of totipotency-associated markers, including MERVL endogenous retroviral elements. A combination of single-cell transcriptional studies and epigenetic analyses identified histone acetylases including the central coactivator and histone acetyltransferase EP300 as critical miR-203 targets in the control of cell specification in early embryos. These data suggest that miR-203 carves the epigenetic rewiring required for early developmental transitions, allowing a timely and correctly paced development, at least partially by fine-tuning EP300 levels.

Indexed as

Cell DifferentiationCell LineageEmbryonic DevelopmentEpigenesis, GeneticGene Expression Regulation, DevelopmentalMicroRNAsAnimalsBlastocystFemaleMiceMice, TransgenicMicroRNAsMIRN203 microRNA, mouse

Identifiers

PMID41811946
PMCPMC12978216

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.